Avanos Medical Insider Lowered Holding By 15% During Last Year
Avanos Medical Insider Lowered Holding By 15% During Last Year
From what we can see, insiders were net sellers in Avanos Medical, Inc.'s (NYSE:AVNS ) during the past 12 months. That is, insiders sold the stock in greater numbers than they purchased it.
從我們所看到的來看,過去12個月中,Avanos Medical,Inc.(紐交所:AVNS)的內部人士是淨賣家。也就是說,內部人士賣出了比購買更多的股票。
Although we don't think shareholders should simply follow insider transactions, we do think it is perfectly logical to keep tabs on what insiders are doing.
雖然我們不認爲股東應該簡單地跟隨內部交易,但我們認爲監控內部人士的行動是很合理的。
Avanos Medical Insider Transactions Over The Last Year
過去一年中的Avanos Medical內部交易
The Senior VP, Michael Greiner, made the biggest insider sale in the last 12 months. That single transaction was for US$153k worth of shares at a price of US$19.16 each. That means that an insider was selling shares at slightly below the current price (US$23.58). As a general rule we consider it to be discouraging when insiders are selling below the current price, because it suggests they were happy with a lower valuation. While insider selling is not a positive sign, we can't be sure if it does mean insiders think the shares are fully valued, so it's only a weak sign. It is worth noting that this sale was only 15% of Michael Greiner's holding. Michael Greiner was the only individual insider to sell shares in the last twelve months.
高級副總裁Michael Greiner在過去12個月中做出了最大的內部交易。那單交易的價值爲15.3萬美元,每股價格爲19.16美元。也就是說,內部人士以略低於當前價格(23.58美元)的價格出售股票。一般來說,如果內部人員以低於當前價格的價格出售股票,那麼這是令人沮喪的,因爲這表明他們對較低估值感到滿意。雖然內部交易的售出不是什麼積極的跡象,但我們不能確定這是否意味着內部人員認爲股票價值已經充分體現,因此這只是一個弱跡象。值得注意的是,這筆交易僅佔Michael Greiner持有的股份的15%。Michael Greiner是過去12個月中唯一一個個人內部人士出售股票的人。
You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!
以下是公司和個人過去12個月的內部交易的可視化描述。如果單擊圖表,您可以查看所有個人交易,包括股票價格、個人和日期!
![big](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240820/0-32265ad40679ef98e91bc29288f77b0c-0-701ef4d435529625bf5280bc1378270f.png/big)
If you like to buy stocks that insiders are buying, rather than selling, then you might just love this free list of companies. (Hint: Most of them are flying under the radar).
如果你喜歡購買內部人員正在購買而不是銷售的股票,那麼你可能會喜歡這份免費的公司列表。(提示:它們中的大部分都被忽視了。)
Does Avanos Medical Boast High Insider Ownership?
Avanos Medical是否擁有高比例內部持股?
Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. We usually like to see fairly high levels of insider ownership. It appears that Avanos Medical insiders own 1.5% of the company, worth about US$15m. We've certainly seen higher levels of insider ownership elsewhere, but these holdings are enough to suggest alignment between insiders and the other shareholders.
測試公司領導人和其他股東之間關係的另一種方法是查看他們擁有多少股份。我們通常希望看到相當高的內部持股比例。看來Avanos Medical的內部人士擁有該公司的1.5%股份,價值約1500萬美元。我們確實在其他地方看到過更高比例的內部持股,但這些持股足以表明內部人士與其他股東的利益基本保持一致。
So What Does This Data Suggest About Avanos Medical Insiders?
這些數據對Avanos Medical內部人員意味着什麼?
There haven't been any insider transactions in the last three months -- that doesn't mean much. Our analysis of Avanos Medical insider transactions leaves us cautious. But it's good to see that insiders own shares in the company. While it's good to be aware of what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. Case in point: We've spotted 1 warning sign for Avanos Medical you should be aware of.
在過去的三個月中沒有內部交易——這意義不大。我們對Avanos Medical內部交易的分析讓我們保持謹慎。但看到內部人士擁有公司的股票是好事。雖然了解內部人員持股和交易的情況很好,但在做出任何投資決策之前,我們也要考慮股票面臨的風險。話說回來:我們已經發現了1個Avanos Medical警告標誌,您應該注意。
Of course Avanos Medical may not be the best stock to buy. So you may wish to see this free collection of high quality companies.
當然,Avanos Medical可能不是最好的股票選擇。因此,您可能希望查看這些高質量公司的免費收藏。
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
對於本文而言,內部人是指向相關監管機構報告其交易的個人。我們目前僅考慮公開市場交易和直接利益的私人處置,但不包括衍生交易或間接利益。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。